Found: 15
Select item for more details and to access through your institution.
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 1, p. 53, doi. 10.1016/j.clgc.2021.11.004
- By:
- Publication type:
- Article
Safety and efficacy of extended dosing intervals of denosumab in patients with solid cancers and bone metastases: a retrospective study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920982859
- By:
- Publication type:
- Article
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 8, p. 2752, doi. 10.1002/cam4.2932
- By:
- Publication type:
- Article
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.701345
- By:
- Publication type:
- Article
Successful treatment of local anaesthetic toxicity using intralipid 20% emulsion following intrathoracic bupivacaine overdose in a cat.
- Published in:
- Journal of Feline Medicine & Surgery Open Reports, 2022, v. 8, n. 1, p. 1, doi. 10.1177/20551169221104552
- By:
- Publication type:
- Article
Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.779915
- By:
- Publication type:
- Article
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1072, doi. 10.1093/oncolo/oyad154
- By:
- Publication type:
- Article
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 239, doi. 10.1093/oncolo/oyac236
- By:
- Publication type:
- Article
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1017, doi. 10.1002/onco.13922
- By:
- Publication type:
- Article
Retrospective Study of Bleeding Risk with Concomitant Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor and Anticoagulation.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2061, doi. 10.1002/onco.13897
- By:
- Publication type:
- Article
Clinical Outcomes and Racial Disparities in Metastatic Hormone‐Sensitive Prostate Cancer in the Era of Novel Treatment Options.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 956, doi. 10.1002/onco.13848
- By:
- Publication type:
- Article
Immune‐Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1742, doi. 10.1002/onco.13868
- By:
- Publication type:
- Article
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 397, doi. 10.1002/onco.13727
- By:
- Publication type:
- Article
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e484, doi. 10.1634/theoncologist.2019-0578
- By:
- Publication type:
- Article
Concordance of the Histopathologic Diagnosis of Concurrent Duodenal and Ileal Biopsy Specimens in Dogs.
- Published in:
- 2021
- By:
- Publication type:
- Abstract